Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31323871 | 0.89 | CHRM2 (0.36) | CHRM2CHRM4CHRM1CHRM3DNM1 | |
| SCHEMBL15028140 | 0.89 | CHRM2 (0.36) | CHRM2CHRM4CHRM1CHRM3DNM1 | |
| SCHEMBL31323883 | 0.89 | CHRM2 (0.36) | CHRM2CHRM4CHRM1CHRM3DNM1 | |
| SCHEMBL20924716 | 0.88 | CHRM2 (0.36) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL15027495 | 0.87 | DNM1 (0.35) | CHRM2CHRM4CHRM1CHRM3DNM1 | |
| SCHEMBL20924798 | 0.82 | CHRM2 (0.36) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL16376199 | 0.81 | CHRM2 (0.32) | CHRM2CHRM4CHRM1CHRM3DNM1 | |
| SCHEMBL15027494 | 0.81 | SIGMAR1 (0.40) | CHRM2CHRM4CHRM1CHRM3DNM1 | |
| SCHEMBL20924789 | 0.79 | SIGMAR1 (0.37) | DNM1EPHX2ALDH1A1LMNASIGMAR1 | |
| SCHEMBL15026847 | 0.79 | SIGMAR1 (0.43) | CHRM2CHRM4CHRM1CHRM3DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2788316-B1 | BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | ALNYLAM PHARMACEUTICALS INC (US) | 2019-04-24 | — | — | EP | disclosed |